Marc Laboratories Limited - Due diligence report

A 360° intelligence report on Marc Laboratories: trust score, financial health, credit view, compliance, directors, growth and distress sign…

1985-04-25 New Delhi, Delhi Active Unlisted Active Compliant
Share
View plans
ML Marc Laboratories Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Marc Laboratories — 360° Intelligence Report

Generated from MCA filings & public records
85/100
Trust Score
Low Risk

Marc Laboratories is assessed as Low Risk with a Trust Score of 85/100. Marc Laboratories is an active public limited indian non-government company incorporated in 1985, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 28 Jun 2026 from the latest processed filings. Marc Laboratories Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
80/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
80/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Consolidated · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.
  • Externally credit-rated (B+).

Charges position: 5 open (155.67 cr) · 15 satisfied (123.09 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited2 48.0 cr
Others3 48.0 cr
Bank Of Baroda2 48.0 cr
Bank Of India10 48.0 cr
Axis Bank Limited2 48.0 cr
State Bank Of India1 48.0 cr
Compliance Score: 80/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 3 court forum(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 80/100
NameDIN / PANDesignationAppointedTenureDIN status
KAPIL DEV MAHTO 01234567 Director 01/04/2018 6 yrs Approved
AMIT KISHORE RASTOGI 01234567 Director 01/04/2018 6 yrs Approved
VIPIN KISHORE RASTOGI 01234567 Director 01/04/2018 6 yrs Approved
PREM KISHORE RASTOGI 01234567 Director 01/04/2018 6 yrs Approved
AKHILESH KUMAR SRIVASTAVA 01234567 Director 01/04/2018 6 yrs Approved
NITIN KISHORE RASTOGI 01234567 Director 01/04/2018 6 yrs Approved
  • 6 directors on the board.
  • No disqualified or deactivated DINs.
  • 5 director exits in 3 years - high churn.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
1 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Marc India Limited Subsidiary Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
EPFO headcount growing - hiring signal.
Operating for 41+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
5 open charge(s) registered - assets are encumbered.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence84/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 5 open charge(s) of 155.67 cr already registered.
  • Compliance record supports lending.
Investor view87/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
20 Nov 2024
Director ceased
BIMLESH KUMAR SRIVASTAVA
27 Aug 2024
Charge created
Hdfc Bank Limited - 9.48 Lakh
16 Apr 2024
Charge created
Hdfc Bank Limited - 90.60 cr
29 Dec 2023
Director ceased
KAPIL DEV MAHTO
Director ceased
VIPIN KISHORE RASTOGI
Director ceased
AKHILESH KUMAR SRIVASTAVA
Director ceased
NITIN KISHORE RASTOGI
15 Apr 2023
Director appointed
KAPIL DEV MAHTO (Director)
Director appointed
AKHILESH KUMAR SRIVASTAVA (Director)
20 Mar 2023
Director appointed
VIPIN KISHORE RASTOGI (Director)
Director appointed
NITIN KISHORE RASTOGI (Director)
27 Sep 2022
Charge created
Others - 40.50 cr
10 Aug 2022
Charge satisfied
Others
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
6 active director(s) / partner(s); board looks stable and experienced.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of B+ from Icra.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Kesar Petroproducts L23209PN1990PLC054829 Ratnagiri, Maharashtra, India
Vasant Chemicals U24110TG1988PTC009208 Shaikpet, Telangana, India
Jipl U33114KA1994PTC015825 Bangalore, Karnataka, India
Srinivasa Cystine Private Ltd U24110TG1983PTC003897 Ap, Telangana, India
Naveentile L26914KA1983PLC005401 Hubli, Karnataka, India
Indfragbiosciences U01403KA2015PTC084380 Bangalore, Karnataka, India
Salvichem U24230MH2005PLC156633 Mumbai, Maharashtra, India
Colorobbia Chemicals India Private Limited U24121GJ2012FTC070752 Sanand, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Marc Laboratories before audits and certifications: compliance score 80/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Marc Laboratories: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Marc Laboratories - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Marc Laboratories pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Marc Laboratories - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Marc Laboratories an active company?

Marc Laboratories has MCA status “Active” with a compliance score of 80/100 (Low Risk).

Is Marc Laboratories financially healthy?

Marc Laboratories has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Marc Laboratories?

Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Marc Laboratories?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 6 active director(s) are on record.

Does Marc Laboratories have loans or charges against its assets?

5 open charge(s) are registered against its assets, and 15 earlier charge(s) stand satisfied.

Is Marc Laboratories up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 80/100 (Low Risk).

Is it risky to lend to Marc Laboratories?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.